RxDoctor Payments Data

Nkechi Quadri, NP

Primary Care · Houston, TXNPI 1669914636

Payments from drug & device makers

$446in general payments, 2019–2025

Across 25 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$104
  • GSK$69
  • Novo Nordisk$45
  • Lilly USA, LLC$44
  • Pfizer$39
  • Amgen$31
  • plus $113 from 6 others

What the payments were for

  • Food & beverage$446100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$446 in reported general payments places this provider in the 55th percentile of 563 primary care providers in Texas.

See all primary care providers in Texas

Medicare billing

Part B allowed, 2024
$9,111
Medicare patients
31
Services billed
130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide32$64,459
JardianceEmpagliflozin44$44,357
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$18,221
LinzessLinaclotide22$17,261
MounjaroTirzepatide11$15,854
EntrestoSacubitril/Valsartan12$13,948
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,268
Albuterol Sulfate HfaAlbuterol Sulfate55$1,278
Gabapentin52$958
Lidocaine19$922
Atorvastatin Calcium111$844
Nifedipine ErNifedipine27$791
Omeprazole50$751
Ventolin HfaAlbuterol Sulfate13$671
Fluticasone Propionate39$532

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$45$64,45932 claims
GSKTrelegy Ellipta$69$18,22126 claims
Lilly USA, LLCMounjaro$44$15,85411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 563 primary care providers in Texas.

Other primary care in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →